PUBLISHER: The Business Research Company | PRODUCT CODE: 1829894
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829894
An arteriotomy closure device (ACD) is a specialized medical tool intended to seal the puncture site in an artery after procedures such as catheterization or angiography. It helps achieve hemostasis by closing the artery, minimizing the risk of bleeding, and promoting a quicker recovery compared to manual compression. ACDs are frequently employed in minimally invasive vascular procedures to improve both patient safety and the efficiency of the procedure.
Arteriotomy closure devices primarily come in two types, active closure devices and passive closure devices. Active closure devices are used to close arterial puncture sites following medical procedures, employing mechanical or mechanical-hemostatic techniques to stop bleeding and support faster recovery. These devices are used in various procedures, including those involving femoral and radial arterial access, and are employed by a variety of healthcare settings, such as hospitals, outpatient care centers, and other medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The arteriotomy closure devices market research report is one of a series of new reports from The Business Research Company that provides arteriotomy closure devices market statistics, including the arteriotomy closure devices industry global market size, regional shares, competitors with the arteriotomy closure devices market share, detailed arteriotomy closure devices market segments, market trends, and opportunities, and any further data you may need to thrive in the arteriotomy closure devices industry. This arteriotomy closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The arteriotomy closure devices market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to an increasing number of minimally invasive surgeries, a growing prevalence of cardiovascular diseases, rising adoption of catheterization procedures, an increasing aging population, and demand for quicker recovery times.
The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the rising incidence of atherosclerosis, the growing number of coronary artery diseases, increased focus on patient safety and comfort, growing healthcare infrastructure in emerging economies, and rising demand for ambulatory surgical centers. Major trends in the forecast period include minimally invasive techniques, adoption of bioresorbable materials, integration of automation in closure procedures, improving procedural efficiency, and innovations in closure devices for large arterial punctures.
The forecast of 6.8% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through shortages of bioabsorbable collagen plugs from Switzerland and vascular closure clips from Germany, potentially delaying post-catheterization wound healing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the arteriotomy closure devices market in the coming years. CVDs encompass a range of disorders that impact the heart and blood vessels. The growing incidence of CVDs is primarily due to increasing risk factors such as poor diets, lack of physical activity, obesity, and an aging population. Arteriotomy closure devices play a critical role in cardiovascular procedures by efficiently sealing arterial puncture sites, reducing the risk of complications, and enhancing recovery after treatments such as angioplasties and catheterizations. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research organization, reported that around 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to rise by an additional 1 million by 2030 and may increase by up to 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases is driving the expansion of the arteriotomy closure devices market.
Leading companies in the arteriotomy closure devices market are focusing on innovation to improve procedural efficiency, enhance patient outcomes, and address the growing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical instrument designed to close venous access sites created by medium-sized catheters or sheaths, helping with hemostasis and supporting patient recovery after interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This device is designed for larger sheaths (10-12F, up to 15F outer diameter) commonly used in procedures such as cryoablation. It features 58% more collagen and a bigger collapsible disc to facilitate rapid hemostasis. This addition to Haemonetics' portfolio of small- and mid-bore vascular closure solutions highlights the company's leadership in advanced closure technology.
In February 2022, Boston Scientific Corporation, a US-based company specializing in medical technology, acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition is intended to strengthen Boston Scientific's product offerings in electrophysiology and structural heart. It also incorporates Baylis Medical's cutting-edge transseptal access solutions. Baylis Medical Company Inc., based in Canada, is a medical device company known for its innovative solutions in cardiovascular procedures.
Major players in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., and Vivasure Medical.
North America was the largest region in the arteriotomy closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arteriotomy closure devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the arteriotomy closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The arteriotomy closure devices market consists of sales of angiograms, catheterizations, and other interventional surgeries. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Arteriotomy Closure Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on arteriotomy closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for arteriotomy closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The arteriotomy closure devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.